Natriuretic Peptides and Programmed Cell Death Markers Together Predict Heart Failure Outcomes
Plasma BNP correlated with soluble Fas (a cell death marker) in heart failure patients, and elevated sFas independently predicted poor prognosis, linking natriuretic peptide signaling to cardiac apoptosis.
Quick Facts
What This Study Found
Plasma BNP correlated with soluble Fas (apoptosis marker) in CHF patients, and sFas independently predicted prognosis, establishing a link between natriuretic peptide signaling and cardiac programmed cell death.
Key Numbers
How They Did This
Cross-sectional study measuring BNP, ANP, N-terminal ANP, soluble Fas, and TNF-alpha in congestive heart failure patients. Correlations and prognostic analysis performed.
Why This Research Matters
Heart failure involves both mechanical dysfunction and cell death. Combining peptide biomarkers (BNP) with apoptosis markers (sFas) could provide a more complete picture of disease severity and trajectory.
The Bigger Picture
The future of heart failure monitoring may involve multi-marker panels that capture different disease mechanisms — hormonal activation, inflammation, and cell death — for comprehensive risk assessment.
What This Study Doesn't Tell Us
Cross-sectional design; causation uncertain. The mechanistic link between BNP and sFas is correlational. Specific sFas cutoffs for clinical use not established.
Questions This Raises
- ?Does BNP directly promote cardiac apoptosis?
- ?Should sFas be added to routine heart failure biomarker panels?
- ?Can anti-apoptotic therapies improve heart failure outcomes?
Trust & Context
- Key Stat:
- Peptides + cell death BNP correlated with apoptosis marker sFas, and sFas independently predicted prognosis — linking heart stress peptides to cardiac cell death
- Evidence Grade:
- Moderate evidence from a cross-sectional study with correlation and prognostic analyses in heart failure patients.
- Study Age:
- Published in 2001. Multi-marker approaches combining natriuretic peptides with inflammatory and apoptotic markers continue to be developed.
- Original Title:
- Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas: plasma soluble Fas as a prognostic predictor in patients with congestive heart failure.
- Published In:
- Journal of cardiac failure, 7(4), 322-8 (2001)
- Authors:
- Tsutamoto, T(4), Wada, A(3), Maeda, K(4), Mabuchi, N, Hayashi, M, Tsutsui, T, Ohnishi, M, Fujii, M, Matsumoto, T, Yamamoto, T, Takayama, T, Kinoshita, M
- Database ID:
- RPEP-00702
Evidence Hierarchy
A snapshot of a population at one point in time.
What do these levels mean? →Frequently Asked Questions
What does it mean that BNP correlates with cell death markers?
When the heart is stressed enough to release more BNP, it's also stressed enough that heart cells start dying (apoptosis). These linked processes suggest severe heart failure involves both overwork and cell loss.
Could monitoring cell death improve treatment?
Yes. If we can detect that heart cells are dying (via sFas), we might intervene with cardioprotective therapies before too much damage occurs — adding precision to heart failure management.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00702APA
Tsutamoto, T; Wada, A; Maeda, K; Mabuchi, N; Hayashi, M; Tsutsui, T; Ohnishi, M; Fujii, M; Matsumoto, T; Yamamoto, T; Takayama, T; Kinoshita, M. (2001). Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas: plasma soluble Fas as a prognostic predictor in patients with congestive heart failure.. Journal of cardiac failure, 7(4), 322-8.
MLA
Tsutamoto, T, et al. "Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas: plasma soluble Fas as a prognostic predictor in patients with congestive heart failure.." Journal of cardiac failure, 2001.
RethinkPeptides
RethinkPeptides Research Database. "Relationship between plasma levels of cardiac natriuretic pe..." RPEP-00702. Retrieved from https://rethinkpeptides.com/research/tsutamoto-2001-relationship-between-plasma-levels
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.